AI assistant
Keros Therapeutics, Inc. — Director's Dealing 2021
Mar 6, 2021
32602_dirs_2021-03-05_fe61fed3-6235-40f8-b22f-2bcf2fbe21b7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Keros Therapeutics, Inc. (KROS)
CIK: 0001664710
Period of Report: 2021-03-03
Reporting Person: Knowles Julius (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-03 | Common Stock | S | 793 | $55.91 | Disposed | 643695 | Indirect |
| 2021-03-03 | Common Stock | S | 518 | $55.91 | Disposed | 429765 | Indirect |
| 2021-03-03 | Common Stock | S | 3004 | $56.95 | Disposed | 640691 | Indirect |
| 2021-03-03 | Common Stock | S | 1958 | $56.95 | Disposed | 427807 | Indirect |
| 2021-03-03 | Common Stock | S | 2903 | $57.79 | Disposed | 637788 | Indirect |
| 2021-03-03 | Common Stock | S | 1894 | $57.79 | Disposed | 425913 | Indirect |
| 2021-03-03 | Common Stock | S | 761 | $58.88 | Disposed | 637027 | Indirect |
| 2021-03-03 | Common Stock | S | 496 | $58.88 | Disposed | 425417 | Indirect |
| 2021-03-04 | Common Stock | S | 1662 | $54.22 | Disposed | 635365 | Indirect |
| 2021-03-04 | Common Stock | S | 1086 | $54.22 | Disposed | 424331 | Indirect |
| 2021-03-04 | Common Stock | S | 2962 | $55.21 | Disposed | 632403 | Indirect |
| 2021-03-04 | Common Stock | S | 1932 | $55.21 | Disposed | 422399 | Indirect |
| 2021-03-04 | Common Stock | S | 1376 | $56.18 | Disposed | 631027 | Indirect |
| 2021-03-04 | Common Stock | S | 895 | $56.18 | Disposed | 421504 | Indirect |
| 2021-03-04 | Common Stock | S | 847 | $57.21 | Disposed | 630180 | Indirect |
| 2021-03-04 | Common Stock | S | 553 | $57.21 | Disposed | 420951 | Indirect |
| 2021-03-04 | Common Stock | S | 193 | $58.03 | Disposed | 629987 | Indirect |
| 2021-03-04 | Common Stock | S | 126 | $58.03 | Disposed | 420825 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.39 to
$56.32 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and
Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in
footnotes (2), (5), (6), (7), (8), (9), (10), (11) and (12).
F3: The securities are held by Partners Innovation Fund, LLC ("PIF I"). Partners Innovation Fund, LLC ("Partners GP I") is the ultimate general
partner of PIF I. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP I and as a result, may be
deemed to share voting and investment power with respect to the shares held by PIF I.
F4: The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC ("Partners GP II") is the ultimate general
partner of PIF II. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP II and as a result, may be
deemed to share voting and investment power with respect to the shares held by PIF II.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.41 to
$57.40 inclusive.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.42 to
$58.38 inclusive.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.46 to
$59.19 inclusive.
F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.76 to $54.72 inclusive.
F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.76 to $55.75 inclusive.
F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.77 to $56.75 inclusive.
F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.80 to $57.59 inclusive.
F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.86 to $58.18 inclusive.